CLDN18 and hilar cholangiocarcinoma: Next, the presence of CLDN18 expression could be observed in 26.5% (n = nine of 34) of the perihilar cholangiocarcinoma (pCCA) subgroup, while 16.1% (n = five of 31) were positive in distal cholangiocarcinoma (dCCA).